Page last updated: 2024-11-11

arugomycin

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

arugomycin: from organism 1098-AV(2); structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6444209
MeSH IDM0119442

Synonyms (4)

Synonym
arugomycin
brn 4507189
2,6-epoxy-2h-naphthaceno(1,2-b)oxocin, arugomycin deriv.
88465-80-9

Research Excerpts

Overview

Arugomycin (AGM) is a new anthracycline antibiotic produced by strain No. 1.

ExcerptReferenceRelevance
"Arugomycin (AGM) is a new anthracycline antibiotic produced by strain No. "( Arugomycin, a new anthracycline antibiotic. I. Taxonomy, fermentation, isolation and physico-chemical properties.
Furihata, K; Hayakawa, Y; Kawai, H; Nakagawa, M; Otake, N; Seto, H; Shimazu, A, 1987
)
3.16
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]